FDA OKs first generic drug under new accelerated pathway

|By:, SA News Editor

The FDA has approved Apotex's potassium chloride oral solution for the treatment and prevention of hypokalemia (low blood potassium) in patients on diuretics and when dietary management with potassium-rich foods is inadequate or diuretic dose reduction is not possible.

The agency approved the generic under its new accelerated pathway for products that lack competition.

Selected tickers: (MYL -2.4%)(PRGO -0.1%)(AKRX -2.5%)(MNK -2.5%)(ENDP +28.1%)(RDY -0.9%)(LCI -2.2%)

Subscribe for full text news in your inbox